| A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial Participants (NCT07717918) | Bausch & Lomb Incorporated | 2026-07-06 |
| Revive Toric RWE Study (NCT06785194) | Bausch & Lomb Incorporated | 2026-05-01 |
| A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy (NCT07412496) | Bausch & Lomb Incorporated | 2026-04-01 |
| A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism (NCT07377474) | Bausch & Lomb Incorporated | 2026-04-01 |
| A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease (NCT07111013) | Bausch & Lomb Incorporated | 2025-12-01 |
| Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy (NCT06618547) | Bausch & Lomb Incorporated | 2025-11-01 |
| Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension (NCT07168902) | Bausch & Lomb Incorporated | 2025-10-24 |
| A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease (NCT07128628) | Bausch & Lomb Incorporated | 2025-10-24 |
| A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy Volunteers (NCT06978244) | Bausch & Lomb Incorporated | 2025-07-29 |
| A Study to Evaluate Concomitant Perfluorohexyloctane Use With Contact Lens Wear (NCT07054606) | Bausch & Lomb Incorporated | 2025-07-02 |
| A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness (NCT06803654) | Bausch & Lomb Incorporated | 2025-05-22 |
| A Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract Extraction (NCT06594185) | Bausch & Lomb Incorporated | 2024-08-29 |
| Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) Lens (NCT06479148) | Bausch & Lomb Incorporated | 2024-08-15 |
| A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months. (NCT06565650) | Bausch & Lomb Incorporated | 2024-07-31 |
| A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction (NCT06333028) | Bausch & Lomb Incorporated | 2024-05-30 |
| A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy (NCT06346340) | Bausch & Lomb Incorporated | 2024-04-30 |
| A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children (NCT06305663) | Bausch & Lomb Incorporated | 2024-03-29 |
| A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease (NCT06309953) | Bausch & Lomb Incorporated | 2024-02-28 |
| 1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact Lenses (NCT06053736) | Bausch & Lomb Incorporated | 2023-10-04 |
| IC-8 Apthera IOL New Enrollment Post Approval Study (NCT06060041) | Bausch & Lomb Incorporated | 2023-09-08 |
| Kalifilcon A Toric Compared to Commercially Available Lenses (NCT06098937) | Bausch & Lomb Incorporated | 2023-09-05 |
| Effects of NOV03 on the Tear Film (NCT05723770) | Bausch & Lomb Incorporated | 2023-08-14 |
| Orientation Characteristics of Daily Disposable Toric Contact Lenses (NCT06069609) | Bausch & Lomb Incorporated | 2023-08-11 |
| Study of Safety and Effectiveness of the Boston Orthokeratology Shaping Lens in the Arise Orthokeratology Lens (NCT05984290) | Bausch & Lomb Incorporated | 2023-07-11 |
| Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution (NCT05815758) | Bausch & Lomb Incorporated | 2023-04-20 |
| A Study to Evaluate the Safety and Effectiveness of a Contact Lens Cleaning and Disinfecting Solution (NCT05565937) | Bausch & Lomb Incorporated | 2023-04-12 |
| Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis (NCT05591755) | Bausch & Lomb Incorporated | 2022-11-18 |
| Evaluation of Product Performance of a New Silicone Hydrogel Multifocal Contact Lens (NCT05660577) | Bausch & Lomb Incorporated | 2022-11-07 |
| Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis (NCT05579730) | Bausch & Lomb Incorporated | 2022-10-12 |
| A Study to Evaluate the Effect of Latanoprostene Bunod Ophthalmic Solution 0.024% on Episcleral Venous Pressure and Outflow Facility in Participants With Ocular Hypertension (NCT04140279) | Bausch & Lomb Incorporated | 2022-05-13 |
| "Efficacy and Safety of Brimonidine Tartrate Preservative-Free Formulation in Adults With Ocular Redness" (NCT05360784) | Bausch & Lomb Incorporated | 2022-05-13 |
| Retrospective Chart Review of enVista Toric 0.9D Intraocular Lenses (NCT05075746) | Bausch & Lomb Incorporated | 2022-03-08 |
| 1-Week Dispensing Evaluation of Kalifilcon A Daily Disposable Multifocal Compared to Ultra for Presbyopia (NCT05325931) | Bausch & Lomb Incorporated | 2022-02-25 |
| 1-Week Dispensing Evaluation of Kalifilcon A Toric Contact Lenses Compared to Ultra for Astigmatism (NCT05320042) | Bausch & Lomb Incorporated | 2022-02-14 |
| Insertion Clinical Study to Evaluate the Orientation Characteristics of Multiple Kalifilcon A Daily Disposable Toric LD213001 Contact Lenses (NCT05129124) | Bausch & Lomb Incorporated | 2021-11-30 |
| 2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses (NCT05126953) | Bausch & Lomb Incorporated | 2021-09-21 |
| Biotrue ONEday Contact Lenses With EPG03 Packaging Solution Compared to Biotrue ONEday Contact Lenses (NCT05129488) | Bausch & Lomb Incorporated | 2021-09-15 |
| Surface Refractive Index Shift of Kalifilcon A Compared With Dailies Total1 and Precision1 Lenses (NCT04840563) | Bausch & Lomb Incorporated | 2021-04-07 |
| Safety and Efficacy of a New Transepithelial Photorefractive Keratectomy Treatment (NCT04698174) | Bausch & Lomb Incorporated | 2021-02-02 |
| Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study) (NCT04140227) | Bausch & Lomb Incorporated | 2020-09-24 |
| Evaluation of Surface Refractive Index Shift of Kalifilcon A Lenses Compared to Dailies Total 1, Precision 1 and Biotrue ONEday Lenses (NCT04555031) | Bausch & Lomb Incorporated | 2020-09-09 |
| Evaluation of Visual Acuity of the Envista One-piece Acrylic Toric IOL MX60ET (NCT05739656) | Bausch & Lomb Incorporated | 2020-08-01 |
| Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study) (NCT04139798) | Bausch & Lomb Incorporated | 2020-07-20 |
| Clinical Study to Evaluate the Safety and Performance of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction (NCT04224155) | Bausch & Lomb Incorporated | 2020-03-10 |
| Safety and Efficacy of Different Add Powers With a New Presbyopic Lasik Treatment Algorithm (NCT04617080) | Bausch & Lomb Incorporated | 2020-01-26 |
| A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50 (NCT04192630) | Bausch & Lomb Incorporated | 2019-11-26 |
| Safety and IOP-Lowering Effects of WB007 (NCT04149899) | Bausch & Lomb Incorporated | 2019-11-14 |
| A Safety and Effectiveness Study of a New Preservative Free Rewetting Drop (NCT04175340) | Bausch & Lomb Incorporated | 2019-11-07 |
| Product Performance of a New Silicone Hydrogel Contact Lens (NCT04901897) | Bausch & Lomb Incorporated | 2019-07-31 |
| A Study With Technolas® TENEO 317 Model 2 Excimer Laser to Treat Participants With Myopia or Myopic Astigmatism (NCT04111757) | Bausch & Lomb Incorporated | 2019-07-25 |
| A Study to Evaluate the Safety and Efficacy of Kalifilcon A Daily Disposable Contact Lens (NCT04158466) | Bausch & Lomb Incorporated | 2019-05-31 |
| A Safety and Effectiveness Study of BL-ABT12 Multi-Purpose Solution for Use by Participants With Soft Contact Lenses (NCT03897751) | Bausch & Lomb Incorporated | 2019-03-08 |
| A Study to Evaluate the Safety and Effectiveness of a Silicone Hydrogel Custom Contact Lens When Compared to Alden Optical HP Sphere Lens (NCT03897712) | Bausch & Lomb Incorporated | 2019-02-27 |
| Evaluate the Safety and Effectiveness of the Biotrue ONEday for Astigmatism (NCT03681808) | Bausch & Lomb Incorporated | 2018-10-10 |
| Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens (NCT03603600) | Bausch & Lomb Incorporated | 2018-05-31 |
| Bausch & Lomb Ophthalmic Viscosurgical Device (OVD) Dispersive (DVisc40) (NCT03511638) | Bausch & Lomb Incorporated | 2018-05-09 |
| A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle (NCT03489941) | Bausch & Lomb Incorporated | 2018-04-07 |
| Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt (NCT03896633) | Bausch & Lomb Incorporated | 2018-02-28 |
| Clinical Study of Approved Contact Lenses (NCT03351101) | Bausch & Lomb Incorporated | 2017-10-23 |